問卷

TPIDB > Principal Investigator

Principal Investigator


Kaohsiung Veterans General Hosptial

Division of Neurology

更新時間:2023-09-19

施景森
  • Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

2Cases

2025-02-01 - 2027-12-31

Phase II

Completed
A randomized, blinded, placebo-controlled phase 2 trial evaluating the safety, tolerability, quantitative pharmacology, and efficacy (MAGIC) of DNTH103 in adult patients with generalized myasthenia gravis.
  • Condition/Disease

    ● Evaluate the safety and tolerability of DNTH103 in patients with generalized myasthenia gravis (gMG) up to week 13.

  • Test Drug

    DNTH103 150 mg/mL

Participate Sites
8Sites

Recruiting8Sites

2023-01-16 - 2025-08-30

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
23Sites

Recruiting13Sites

Terminated5Sites